Skip to main content

Table 3 Outcome analysis comparing empiric β-lactam versus vancomycin, adjusted for age, age-adjusted Charlson-comorbidity index, infectious diseases consultation, infective endocarditis and time to receipt of empiric antibiotics

From: Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia

Outcomes

Crude OR (95 % CI)

p value

Adjusted OR (95 % CI)

p value

28-day mortality

0.60 (0.23–1.55)

0.29

0.85 (0.27–2.67)

0.78

90-day mortality

0.56 (0.28–1.15)

0.11

0.88 (0.36–2.17)

0.79

 

Ratio of mean (95 % CI)

p value

Adjusted ratio of mean (95 % CI)

p value

Duration of bacteremia

0.77 (0.64–0.93)

0.01

0.77 (0.62–0.95)

0.01

Hospital length-of-stay

0.85 (0.68–1.07)

0.16

0.86 (0.66–1.10)

0.23

  1. Duration of bacteremia was further adjusted for surgical source control
  2. OR odds ratio, CI confidence interval